Boothbay Fund Management’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-21,627
| Closed | -$340K | – | 2855 |
|
|
2022
Q2 | $340K | Hold |
21,627
| – | – | 0.01% | 1387 |
|
|
2022
Q1 | $329K | Buy |
+21,627
| New | +$329K | 0.01% | 1558 |
|
|
2021
Q4 | – | Sell |
-12,633
| Closed | -$110K | – | 2402 |
|
|
2021
Q3 | $110K | Sell |
12,633
-4,615
| -27% | -$42.1K | ﹤0.01% | 1783 |
|
|
2021
Q2 | $176K | Buy |
+17,248
| New | +$182K | 0.01% | 1569 |
|
|
2019
Q3 | – | Sell |
-23,563
| Closed | -$98K | – | 957 |
|
|
2019
Q2 | $98K | Sell |
23,563
-12,552
| -35% | -$66.2K | 0.01% | 667 |
|
|
2019
Q1 | $227K | Sell |
36,115
-45,141
| -56% | -$316K | 0.02% | 581 |
|
|
2018
Q4 | $527K | Buy |
+81,256
| New | +$622K | 0.08% | 254 |
|
|
2018
Q2 | – | Sell |
-105,917
| Closed | -$726K | – | 944 |
|
|
2018
Q1 | $726K | Buy |
105,917
+68,448
| +183% | +$435K | 0.09% | 238 |
|
|
2017
Q4 | $247K | Hold |
37,469
| – | – | 0.04% | 512 |
|
|
2017
Q3 | $208K | Sell |
37,469
-28,266
| -43% | -$191K | 0.03% | 504 |
|
|
2017
Q2 | $507K | Buy |
+65,735
| New | +$555K | 0.11% | 231 |
|
|
2016
Q3 | – | Sell |
-40,023
| Closed | -$381K | – | 832 |
|
|
2016
Q2 | $381K | Buy |
+40,023
| New | +$436K | 0.15% | 188 |
|
|
2015
Q2 | – | Sell |
-33,642
| Closed | -$227K | – | 506 |
|
|
2015
Q1 | $227K | Sell |
33,642
-14,011
| -29% | -$56.4K | 0.15% | 207 |
|
|
2014
Q4 | $161K | Buy |
+47,653
| New | +$153K | 0.12% | 265 |
|
Other funds holding NPTN
Boothbay Fund Management's NPTN Position: Q3 2022 in Review
Boothbay Fund Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 21,627 shares — an estimated $340K sold.
Boothbay Fund Management first reported a position in NPTN in Q4 2014 and held it in 14 quarters. The position peaked at $726K in Q1 2018. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Boothbay Fund Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Boothbay Fund Management sold 21,627 NEOPHOTONICS CORP shares in Q3 2022, an estimated $340K.
- Boothbay Fund Management first reported a position in NEOPHOTONICS CORP in Q4 2014 and held it in 14 quarters.
- Boothbay Fund Management's NEOPHOTONICS CORP position peaked at $726K in Q1 2018.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.